First-pass extracted concept

cell and gene therapy

Candidate: concept label1 source documents4 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Aliases

CGT

Evidence Snippets

In this context, cell and gene therapy (CGT) emerges as a promising frontier in the new immunotherapy era with its remarkable flexibility, diversity, and compatibility.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1primary paper2025MEDDOI PubMed

1 evidence snippet 4 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1mechanistic scopesupports2025Source 1DOI PubMed

Cell and gene therapy can target cross-talk between cancer cells and the tumor immune microenvironment from cellular and molecular perspectives.

Claim 2microenvironment remodelingsupports2025Source 1DOI PubMed

Cell and gene therapy not only remodels the local tumor immune microenvironment but also has long-term effects on the systemic immune response.

Claim 3therapeutic strategy positioningsupports2025Source 1DOI PubMed

Cell and gene therapy is presented as a promising immunotherapy frontier for solid tumors because of its flexibility, diversity, and compatibility.

Claim 4treatment paradigmsupports2025Source 1DOI PubMed

The development of cell and gene therapy is proposed to shift cancer treatment from targeting tumor tissues alone toward restoring disrupted cancer-immune balance as a whole.